CLAG-M or FLAG-Ida Chemotherapy Followed Immediately by Related/Unrelated Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1 Study
Latest Information Update: 25 Feb 2025
At a glance
- Drugs Ciclosporin (Primary) ; Cladribine (Primary) ; Cyclophosphamide (Primary) ; Cytarabine (Primary) ; Filgrastim (Primary) ; Mitoxantrone (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary)
- Indications Acute myeloid leukaemia; Chronic myelomonocytic leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
- Focus Therapeutic Use
- 20 Feb 2025 Planned End Date changed from 31 Dec 2027 to 17 Mar 2027.
- 20 Feb 2025 Planned primary completion date changed from 31 Dec 2025 to 28 Feb 2027.
- 09 Jan 2024 Planned End Date changed from 31 Dec 2025 to 31 Dec 2027.